Floatz logo

LIDOCAINE

Neuroma

Danish Pain Research CenterSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Neuroma cohort.

Asset / SponsorPhaseRating
Algrx 4975
AlgoRx Pharmaceuticals
Phase 2B
Onabotulinum Toxin Type-A
Southern Illinois University
Phase 2CCC
AUTOLOGOUS CONDITIONED PLASMA
Ukrainian Society of Regional Anesthesia and Pain Therapy
N/AD

Same molecule, other indications

LIDOCAINE is also rated in:

peripheral neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative ·
78 / 100
View asset →
post-operative pain, non-human animalDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →